Capio’s Nomination Committee proposes Board members for the Annual General Meeting 2017
The Nomination Committee of Capio AB (publ) has resolved to propose to the Annual General Meeting (AGM) to be held on 3 May 2017 the election of Michael Wolf, Gunilla Rudebjer and Karl Åberg as new Board members. Furthermore, the Nomination Committee proposes re-election of the Board members Gunnar Németh, Fredrik Näslund, Birgitta Stymne Göransson, Pascale Richetta and Michael Flemming. The Nomination Committee proposes election of Michael Wolf as new Chairman of the Board.
Anders Narvinger and Gun Nilsson have declined re-election.
”I am satisfied with Capio now being established on Nasdaq Stockholm. At the same time, after six years as Chairman, it is now time for Capio to take the next step and I have consequently declared that I am not available for re-election.” says Anders Narvinger.
During Anders Narvinger’s time as chairman, the company’s strategy has been defined and deepened around Modern Medicine and Modern Management. With this strategy, Capio provides healthcare with higher quality at a lower cost across the five countries where the company operates, in a Europe with aging population and increased healthcare demand.
Anders Narvinger has also led Capio from being a privately owned company into becoming a public one through the IPO in Stockholm during the summer of 2015. The IPO adds to Capio’s increased legitimacy, as well as the potential to use the stock exchange as source of future funding.
With this suggested change of chairman, the next phase of Capio’s development starts – with the starting point in the decided strategy, Capio should increase the speed of expansion, both organically and through acquisitions, in existing and new markets. In short, a new phase of increased growth.
“The Nomination Committee proposes that the work in the board in this new phase should be chaired by Michael Wolf. He has a comprehensive and successful career managing international service companies in the financial sector. His task will be to focus the work of the board on the growth agenda and together with the company’s management drive and support that future development of Capio”, concludes Robert Furuhjelm, Nordic Capital VI Limited, the Chairman of the Nomination Committee.
The complete proposals from the Nomination Committee will be presented in the notice of the AGM.
The Nomination Committee, in anticipation of the 2017 AGM, consists of Robert Furuhjelm (Nordic Capital VI Limited), Joakim Rubin (Zeres Capital), Per Hesselmark (R12 Kapital), Per Colleen (Fjärde AP-fonden), Bo Lundgren (Swedbank Robur fonder) and the Chairman of the Board Anders Narvinger. Robert Furuhjelm is the Chairman of the Nomination Committee.
Summary of biographies, new Board members
Michael Wolf (born 1963) most recent position was as President & CEO of the Swedish/Baltic banking group Swedbank AB (publ). Prior to joining Swedbank, Michael was President & CEO of Intrum Justitia AB and before that he held several different leading positions at the insurance company Skandia, including CEO Skandia Group Germany, CIO Skandia Group and Executive Vice President, Head of Division Europe & Latin America. Michael is currently Chairman of the Stockholm Chamber of Commerce and the Anna Lindh Academy. He holds a Degree in Business and Administration from Stockholm University.
Gunilla Rudebjer (born 1959) is currently partner at Blomqvist & Rudebjer HB. Gunilla has extensive experience from the service industry and has held several positions as Chief Financial Officer in both public and private companies, such as Scandic Hotels, Cision, Parks & Resorts Scandinavia, Mandator and TUI Nordic. Gunilla serves as Board member and Chairman of the Audit Committee in Ambea AB. She holds a M.Sc. of Business and Economics from Stockholm School of Economics.
Karl Åberg (born 1979) is currently Partner at Zeres Capital, based in Stockholm. Prior to establishing Zeres Capital, Karl was a Partner at CapMan and before that he worked in the Investment Banking department of Handelsbanken Capital Markets. Karl is currently a board member of Eltel. He holds a M.Sc. in Economics and Business Administration from Stockholm School of Economics.
For further information, please contact:
Robert Furuhjelm, Chairman of the Nomination Committee
Telephone: +46 76 111 34 14
This information is information that Capio AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.15 CET on 23 March 2017.
Capio AB (publ) is a leading, pan-European healthcare provider offering a broad range of high quality medical, surgical and psychiatric healthcare services through its hospitals, specialist clinics and primary care units. Since the Danish operation was acquired at the beginning of 2017, Capio operates in five countries; Sweden, Norway, Denmark, France and Germany. In 2016, Capio’s 12,435 employees provided healthcare services during 4.7 million patient visits across the Group’s facilities, generating net sales of MSEK 14,069. Capio operates across three geographic segments: Nordic (54% of Group net sales 2016), France (38% of Group net sales 2016) and Germany (8% of Group net sales 2016). For more information about Capio, please see www.capio.com.